About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pemetrexed in Advanced Non-small Cell Lung Cancer

Pemetrexed in Advanced Non-small Cell Lung Cancer

NCT01193959·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Armando Santoro, MD

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Histologically confirmed diagnosis of advanced non-small cell lung cancer - Tumor tissue available at our institution
Patients treated with single agent pemetrexed for metastatic disease
Availability of full clinical data

You may not be if

Cytological diagnosis of advanced Non-small cell lung cancer
Lack of tumor tissue at our institution
Lack of full clinical data

The record

StatusCompleted

PhaseNo phase

Taking part33

StartedSep 2010

UpdatedSep 10, 2022

Conditions

Non-small Cell Lung Cancer (NSCLC)

Where1

Istituto Clinico Humanitas
Rozzano, Milano, Italy